These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases. Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969 [TBL] [Abstract][Full Text] [Related]
6. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity. Monti DM; D'Alessio G J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533 [TBL] [Abstract][Full Text] [Related]
7. Increasing the potency of a cytotoxin with an arginine graft. Fuchs SM; Rutkoski TJ; Kung VM; Groeschl RT; Raines RT Protein Eng Des Sel; 2007 Oct; 20(10):505-9. PubMed ID: 17954521 [TBL] [Abstract][Full Text] [Related]
13. A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells. Vert A; Castro J; Ribó M; Benito A; Vilanova M Oncotarget; 2016 Apr; 7(14):18309-24. PubMed ID: 26918450 [TBL] [Abstract][Full Text] [Related]
14. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents. Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259 [TBL] [Abstract][Full Text] [Related]
15. Endowing human pancreatic ribonuclease with toxicity for cancer cells. Leland PA; Staniszewski KE; Kim BM; Raines RT J Biol Chem; 2001 Nov; 276(46):43095-102. PubMed ID: 11555655 [TBL] [Abstract][Full Text] [Related]
16. A novel biological actions acquired by ribonuclease through oligomerization. Libonati M; Gotte G; Vottariello F Curr Pharm Biotechnol; 2008 Jun; 9(3):200-9. PubMed ID: 18673285 [TBL] [Abstract][Full Text] [Related]
17. Human angiogenin is a potent cytotoxin in the absence of ribonuclease inhibitor. Thomas SP; Hoang TT; Ressler VT; Raines RT RNA; 2018 Aug; 24(8):1018-1027. PubMed ID: 29748193 [TBL] [Abstract][Full Text] [Related]
18. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation. Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118 [TBL] [Abstract][Full Text] [Related]
19. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases. Leich F; Stöhr N; Rietz A; Ulbrich-Hofmann R; Arnold U J Biol Chem; 2007 Sep; 282(38):27640-6. PubMed ID: 17635931 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization, and Preliminary In Vitro Cytotoxic Evaluation of a Series of 2-Substituted Benzo [ Linares-Anaya O; Avila-Sorrosa A; Díaz-Cedillo F; Gil-Ruiz LÁ; Correa-Basurto J; Salazar-Mendoza D; Orjuela AL; Alí-Torres J; Ramírez-Apan MT; Morales-Morales D Molecules; 2021 May; 26(9):. PubMed ID: 34066820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]